The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

Rhea-AI Summary

The Joint Corp (NASDAQ: JYNT) announced on Nov 5, 2025 that its board authorized an additional $12 million for its stock repurchase program.

Management said this follows completion of the first $5 million tranche, which repurchased 540,000 shares between August and October. Repurchases may occur in open-market or privately negotiated transactions and will be made at the discretion of the company’s finance committee, subject to securities laws and market conditions. The program does not obligate the company to buy any specific amount of common stock.

Positive

• Board authorized an additional $12 million for share repurchases
• Completed first tranche: $5 million bought 540,000 shares (Aug–Oct)

Negative

• Repurchases are discretionary and subject to market conditions, limiting predictability
• Program does not obligate the company to acquire any specific amount of stock

SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic^® network, announced that its board of directors has authorized an additional $12 million for its stock repurchase program.

“We are executing on our plan to reignite growth and increase profitability and continue to believe that our asset-light franchise model, growth opportunity, and long-term valuation are not fully recognized in our current share price,” said Chief Executive Officer, President and Director of The Joint Corp., Sanjiv Razdan. “Therefore, following the completion of the first $5 million tranche of the stock repurchase program, which resulted in the buyback of 540,000 shares between August and October, we have extended the authorization by an additional $12 million. This underscores our commitment to disciplined capital allocation that delivers value for our shareholders.”

Repurchases may be made from time to time in open market transactions, privately negotiated transactions, or by other means, in accordance with applicable securities laws and are subject to market conditions and other factors. The timing, frequency and amount of any repurchases will be determined by the company’s finance committee of the board of directors at their discretion. The stock repurchase program does not obligate the company to acquire any particular amount of common stock.

About The Joint Corp. (NASDAQ: JYNT)

The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale and with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” list of 40 smartest growing brands. Entrepreneur named The Joint “No. 1 in Chiropractic Services,” and it is regularly ranked on the publication’s “Franchise 500,” the “Fastest-Growing Franchises,” and the “Best of the Best” lists, as well as its “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners” lists. SUCCESS named the company as one of the “Top 50 Franchises” in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.

Business Structure

The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.

Forward-Looking Statements

This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Words such as, "anticipates," "believes," "continues," "estimates," "expects," "goal," "objectives," "intends," "may," "opportunity," "plans," "potential," "near-term," "long-term," "projections," "assumptions," "projects," "guidance," "forecasts," "outlook," "target," "trends," "should," "could," "would," "will," and similar expressions are intended to identify such forward-looking statements. Specific forward-looking statements made in this press release include, among others, our plan to reignite growth and increase profitability; our belief that our asset-light franchise model, growth opportunity, and long-term valuation are not fully recognized in our current share price; and our belief that the extension of the stock repurchase program underscores our commitment to disciplined capital allocation that delivers value for our stockholders. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, which has increased our costs and which could otherwise negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Media Contact:
Margie Wojciechowski, The Joint Corp., margie.wojciechowski@thejoint.com

Investor Contact:
Richard Land, Alliance Advisors IR, thejointinvestor@allianceadvisors.com 973-873-7686

FAQ

What did The Joint Corp (JYNT) announce on Nov 5, 2025 regarding share repurchases?

The board authorized an additional $12 million for the company's stock repurchase program.

How many shares did The Joint Corp repurchase in the first tranche and when?

The company repurchased 540,000 shares between August and October using a $5 million tranche.

Will The Joint Corp (JYNT) be required to buy a set amount of stock under the program?

No; the program explicitly does not obligate the company to acquire any particular amount of common stock.

How will The Joint Corp execute the authorized repurchases under the JYNT program?

Repurchases may be made in the open market, via privately negotiated transactions, or by other means, at the finance committee's discretion.

Does The Joint Corp set timing and amount for JYNT repurchases?

Timing, frequency, and amount of any repurchases will be determined by the company's finance committee at its discretion.